S. Goldmann

发表

Development of an Efficient and Scalable Biocatalytic Route to (3R)-3-Aminoazepane: A Pharmaceutically Important Intermediate

Zhongqing Wang, Chen Minghong, Feng Yahui, 2017 .

Stereochemistry of a [2,3] sigmatropic allyl-sulfoxide/allyl sulfenate rearrangement

R. W. Hoffmann, S. Goldmann, R. Gerlach, 1978 .

1,4‐Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities

S. Goldmann, J. Stoltefuss, 1991 .

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model.

K. Schlemmer, S. Wohlfeil, A. Paessens, 2002, Antiviral research.

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo.

J. Trappe, S. Goldmann, K. Henninger, 2001, Antiviral research.

Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein

Lai Wei, D. Jiang, Yingjun Zhang, 2017, Journal of medical virology.

Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite.

W. Stalmans, F. Vanstapel, S. Goldmann, 2000, Diabetes.

A new type of Ca-channel modulation by a novel class of 1,4-dihydropyridines.

S. Hallermann, M. Bechem, S. Goldmann, 1996, Life sciences.

Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly

R. Schinazi, M. Feitelson, Guoyi Wu, 2013, Antimicrobial Agents and Chemotherapy.

Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines.

M. Schramm, L. Born, S. Goldmann, 1990, Journal of medicinal chemistry.

Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids

B. Beckermann, U. Pleiss, K. Schlemmer, 2003, Science.

1,4-Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities

S. Goldmann, J. Stoltefuss, 1992 .

4,4‐Disubstituierte 1,4‐Dihydropyridine durch intramolekulare Addition von Carbanionen an Pyridine

S. Goldmann, 1981 .

Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3‐isopropyl 4‐(2‐chlorophenyl)‐1,4‐dihydro‐1‐ethyl‐2‐methyl‐pyridine‐3,5,6‐tricarboxylate

S. Zographos, N. Oikonomakos, K. Tsitsanou, 1999, Protein science : a publication of the Protein Society.

Rotational Barriers of 4‐Aryl‐1, 4‐dihydropyridines (Ca Antagonists)

S. Goldmann, W. Geiger, 1984 .

3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4.

Yunhao Wei, Biao Nie, Yingjun Zhang, 2018, Journal of medicinal chemistry.

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.

J. Trappe, J. Herrington, S. Goldmann, 2001, The Journal of antimicrobial chemotherapy.

Further Optimization of a Scalable Biocatalytic Route to (3R)-N-Boc-3-aminoazepane with Immobilized ω-Transaminase

Bin Liu, Zhongqing Wang, Minghong Chen, 2019, Organic Process Research & Development.

Original articles Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action

J. Trappe, J. Herrington, S. Goldmann, 2001 .

Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).

Yingjun Zhang, Zhonghua Luo, S. Goldmann, 2017, Bioorganic & medicinal chemistry.

Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction.

S. Goldmann, J. Stoltefuss, L. Born, 1992, Journal of medicinal chemistry.

Identification, Characterization, Synthesis, and Strategy for Minimization of Potential Impurities Observed in the Synthesis of Solithromycin

Zhongqing Wang, Zhonghua Luo, S. Goldmann, 2017 .

The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor.

L. Johnson, K. Watson, S. Zographos, 1997, Structure.